PainSquad+: A Smartphone App to Support Real-time Pain Management for Adolescents With Cancer
NCT02901834 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2018-01-03
Summary
Adolescents with cancer (AWC) are in a unique developmental stage that may mean pain characteristics, the impact of pain, and pain treatment outcomes are different in adolescents compared to children and adults. In response, we will develop and test the PainSquad+ pain management smartphone app. First, we will conduct usability testing to refine PainSquad+ so that it is useable, acceptable and understandable for AWC. Secondly we will: (a) test the feasibility of conducting a large-scale PainSquad+ experiment and (b) begin to examine how effective PainSquad+ is at helping adolescents manage pain. We hope that once developed and tested for effectiveness, PainSquad+ will improve pain treatment and ultimately quality of life in AWC.
Conditions
- Therapy-Associated Cancer
Sponsors & Collaborators
-
The Hospital for Sick Children
lead OTHER
Principal Investigators
-
Jennifer Stinson, RN, PhD · The Hospital for Sick Children
Eligibility
- Min Age
- 12 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2016-04-30
- Completion
- 2016-05-31
More Related Trials
-
Early Treatment With Invasive Technique in Cancer Pain Management
NCT05594459 ·Status: UNKNOWN ·Phase: NA
-
Sublingual Fentanyl for the Management of Breakthrough Pain
NCT02514252 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer Patients
NCT00684632 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain
NCT05674240 ·Status: COMPLETED
-
Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients.
NCT00262678 ·Status: COMPLETED ·Phase: PHASE3
-
Application Software in Dosage Adjustment for Advanced Cancer Patients With Pain
NCT03016364 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain
NCT03564548 ·Status: UNKNOWN ·Phase: PHASE2
-
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain
NCT00666211 ·Status: COMPLETED ·Phase: PHASE3
-
Using Technology to Track Pain and Pain-related Outcomes
NCT04267588 ·Status: RECRUITING
-
Pain: Screen and Treat
NCT01716780 ·Status: UNKNOWN ·Phase: PHASE3
-
Reduction in Pain Intensity Following IV or Oral Pain-relieving Products
NCT02678416 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics and Safety of MNK-155 in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain
NCT02767349 ·Status: WITHDRAWN ·Phase: PHASE1
-
Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain
NCT02459964 ·Status: COMPLETED ·Phase: PHASE4
-
Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain
NCT00378937 ·Status: COMPLETED ·Phase: PHASE4
-
Characterization of Acute Pain
NCT07336264 ·Status: RECRUITING
-
Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients
NCT00263575 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain
NCT00225797 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer
NCT00269737 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients
NCT00842829 ·Status: TERMINATED ·Phase: PHASE4
-
Real World Study of Oxycodone Sustained-release Tablets for Patients With Moderate to Severe Cancer Pain
NCT05962294 ·Status: UNKNOWN
-
Evaluation of a Patient-Centred, Multidisciplinary Opioid Tapering Program for Individuals With Chronic Non-Cancer Pain on Long Term Opioid Therapy
NCT04902547 ·Status: COMPLETED ·Phase: NA
-
An Observational, Non-Interventional Trial to Assess Patient Satisfaction and Safety of Subsys™ Spray.
NCT01901718 ·Status: TERMINATED
-
Clinical Use and Safety of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer
NCT00269763 ·Status: COMPLETED ·Phase: PHASE3
-
Nalbuphine Versus Morphine for Mucositis Pain in Pediatric Cancer Patients
NCT03825887 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Fentanyl ETHYPHARM for Breakthrough Pain in Opioid-treated Patients With Cancer
NCT01842893 ·Status: COMPLETED ·Phase: PHASE3